These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22558780)

  • 21. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of a nursing model to understand diarrhea and the role of probiotics in patients with inflammatory bowel disease.
    Savard J; Sawatzky JA
    Gastroenterol Nurs; 2007; 30(6):418-23; quiz 424-5. PubMed ID: 18156958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of prebiotics and probiotics on enteric flora.
    de Simone C
    J Pediatr Gastroenterol Nutr; 2005 Apr; 40 Suppl 1():S40. PubMed ID: 15805848
    [No Abstract]   [Full Text] [Related]  

  • 24. [New therapies of chronic inflammatory bowel disease: anti-TNF antibodies and probiotics. The Danish Society of Gastroenterology].
    Kjeldsen J; Brynskov J; Madsen JR
    Ugeskr Laeger; 2001 Mar; 163(12):1707. PubMed ID: 11284407
    [No Abstract]   [Full Text] [Related]  

  • 25. Do probiotics have a role in the management of inflammatory bowel disease?
    Morris JD; Diamond KA; Balart LA
    J La State Med Soc; 2009; 161(3):155-9. PubMed ID: 19772038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.
    Gassull MA
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():90-5. PubMed ID: 16961752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Probiotic therapy: mechanisms of action and indications in adult gastrointestinal disease].
    Glintborg B; Nielsen AM
    Ugeskr Laeger; 2004 Jan; 166(3):135-9. PubMed ID: 14870638
    [No Abstract]   [Full Text] [Related]  

  • 28. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
    Geier MS; Butler RN; Howarth GS
    Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease.
    Karimi O; Peña AS
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S136-41. PubMed ID: 18806706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The probiotics effectiveness in the therapy of inflammatory bowel diseases].
    Khalif IL; Golovenko AO; Dikshteĭn II; Belous SS
    Eksp Klin Gastroenterol; 2013; (3):3-10. PubMed ID: 24294765
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel and future medical management of inflammatory bowel disease.
    Summers RW
    Surg Clin North Am; 2007 Jun; 87(3):727-41. PubMed ID: 17560422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Probiotics and intestinal inflammatory disorders in infants and children.
    Vanderhoof JA
    J Pediatr Gastroenterol Nutr; 2000; 30 Suppl 2():S34-8. PubMed ID: 10749399
    [No Abstract]   [Full Text] [Related]  

  • 33. Paenibacillus pectinilyticus sp. nov., isolated from the gut of Diestrammena apicalis.
    Park DS; Jeong WJ; Lee KH; Oh HW; Kim BC; Bae KS; Park HY
    Int J Syst Evol Microbiol; 2009 Jun; 59(Pt 6):1342-7. PubMed ID: 19502313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolving knowledge and therapy of inflammatory bowel disease.
    Korzenik JR; Podolsky DK
    Nat Rev Drug Discov; 2006 Mar; 5(3):197-209. PubMed ID: 16518373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prebiotics, synbiotics and inflammatory bowel disease.
    Steed H; Macfarlane GT; Macfarlane S
    Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroenteric pathology and probiotics: from myth to scientific evidence. Current aspects.
    Caramia G
    Minerva Gastroenterol Dietol; 2009 Sep; 55(3):237-72. PubMed ID: 19829283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probiotics, prebiotics, and new foods.
    Capurso L; Morelli L
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S109-10. PubMed ID: 18806698
    [No Abstract]   [Full Text] [Related]  

  • 39. Critical evaluation of probiotic activity of lactic acid bacteria and their effects.
    Heczko PB; Strus M; Kochan P
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():5-12. PubMed ID: 17242483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microecology as a target for therapeutic intervention in inflammatory bowel disease.
    Guarner F
    IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.